Fertility Preservation for the Young Breast Cancer Patient

被引:0
作者
Shari B. Goldfarb
Sabrina A. Kamer
Bridget A. Oppong
Anne Eaton
Sujata Patil
Manuela J. Junqueira
Cristina Olcese
Joanne F. Kelvin
Mary L. Gemignani
机构
[1] Memorial Sloan Kettering Cancer Center,Breast Medicine Service, Department of Medicine
[2] Memorial Sloan Kettering Cancer Center,Health Outcomes Research Group, Department of Epidemiology and Biostatistics
[3] Weill Cornell Medical College,Department of Medicine
[4] Georgetown University Hospital,Department of Surgery
[5] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Biostatistics
[6] Memorial Sloan Kettering Cancer Center,Breast Service, Department of Surgery
[7] Memorial Sloan Kettering Cancer Center,undefined
来源
Annals of Surgical Oncology | 2016年 / 23卷
关键词
Fertility Preservation; Early Referral; Memorial Sloan Kettering Cancer Center; Reproductive Endocrinologist; Fertility Preservation Option;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1530 / 1536
页数:6
相关论文
共 80 条
[1]  
Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer. 136 E359-E386
[2]  
Soerjomataram I(2008)Gene expression profiling of breast cancer Adv Surg. 42 249-260
[3]  
Dikshit R(2015)Cancer statistics, 2015 CA Cancer J Clin. 65 5-29
[4]  
Bao T(2010)Clinical significance of the 21-gene signature (oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population Cancer. 116 3112-3118
[5]  
Davidson NE(2010)“Informed and uninformed decision making”: women’s reasoning, experiences and perceptions with regard to advanced maternal age and delayed childbearing: a meta-synthesis Int J Nurs Stud. 47 1317-1329
[6]  
Siegel RL(2006)Factors influencing women’s decisions about timing of motherhood J Obstet Gynecol Neonatal Nurs. 35 625-633
[7]  
Miller KD(2014)Estimates of young breast cancer survivors at risk for infertility in the U.S Oncologist. 19 814-822
[8]  
Jemal A(2012)What lies behind chemotherapy-induced ovarian toxicity? Reproduction. 144 153-163
[9]  
Toi M(2007)The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane Am J Clin Oncol. 30 126-132
[10]  
Iwata H(2015)Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy N Engl J Med. 372 923-932